Latest News

21 May 2020

Some Patients with Bladder Cancer "Can't Wait" for Treatment During the COVID-19 Pandemic

Bladder cancer is associated with significant illness and mortality, particularly if treatment is delayed. Writing in the journal Bladder Cancer, researchers have outlined recommendations for treatment of both muscle invasive and non-muscle invasive bladder cancer during the COVID-19 pandemic based on data from trials and prior studies, and taking into account the current strains on the healthcare system.

31 October 2018

Messing Honored for Career of Innovation and Leadership in Urological Care

Edward Messing

Rochester, NY, USA – Leading researchers and clinicians from across the globe gathered in Rochester on October 18–19 to recognize the career of Edward Messing, MD, FACS, and his 35 years of accomplishments in improving care for individuals with bladder, kidney, prostate, and testicular cancer. The Festschrift honoring Messing, a professor in the University of Rochester Medical Center (URMC) Department of Urology and the Wilmot Cancer Institute, was the subject of a special edition of the journal Bladder Cancer.


Subscribe to Latest News